International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 1.13.2022
older couple with masks
myeloma patient getting covid booster shot
Seeking COVID-19 Clarity for Myeloma Patients
IMF Chairman of the Board Dr. Brian G.M. Durie provides answers to growing concerns from myeloma patients because of the omicron spread. Get firsthand information about the omicron variant and helpful advice on COVID-19 testing, vaccines, boosters, and the like.
understanding abecma minute banner
Understanding ABECMA® (idecabtagene vicleucel)
Abecma® (idecabtagene vicleucel, “ide-cel”) is the first-in-class BCMA-directed CAR T-cell immunotherapy approved by the U.S. Food and Drug Administration for use in myeloma. Abecma is a personalized immune cell therapy delivered as a one-time infusion, manufactured for each individual patient using the patient’s own white blood cells. The digital version of the booklet is available for viewing and downloading at the IMF website.
covid 19 booster shot needle
Read Up on the Latest COVID-19 Updates and Recommendations from the IMF
As COVID-19 cases continue to rise due to the omicron variant, catch up on the latest updates, FAQs, and recommendations on COVID-19 vaccines, boosters, testing, and antiviral treatments for myeloma patients.
visit now button
blocks that spells give on hands
The Gift That Keeps on Giving: Start Your Own IMF Fundraiser For 2022!
Want to do something meaningful for others as a goal for 2022? Holding a myeloma fundraiser and raising public awareness in your community should be on your list! The IMF team is here to explore event ideas and share experiences with you for a successful fundraiser. For more info, email Suzanne Battaglia, IMF Senior Director, Member Events at, or call (800) 452-2873, ext. 227.
start now button
heart made by hands
Join the IMF’s Hope Society and Support the Myeloma Community All-Year Long
Help us cultivate a future of health and hope by joining the International Myeloma Foundation’s Hope Society. Monthly gifts starting at $10 support IMF core programs, including educational events, publications, the toll-free InfoLine, and more.
join now button
smoldering myeloma treatment questions
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
Should smoldering myeloma patients start treatment?
Watch Now
Online Patient Forum

Smart Patients: Join the Conversation
Clinical Trial Fact Sheets

CANOVA Trial (Accruing)

Phase II Relapsed or Refractory Venetoclax Trial (Accruing)

Phase I/II Trial Using a Venetoclax Combination With or Without Bortezomib (Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)
Ongoing Replays
Watch the Replay
IMWG Conference Series: ASH 2021

Watch the Replay
Advances in Myeloma Treatments Webinar

Watch the Replay
COVID-19 and Myeloma Webinar

Watch the Replay
Regional Community Workshop

See also, all of our events.

We Thank Our Sponsors:

Amgen, Bristol Myers Squibb, GSK, Karyopharm Therapeutics, Oncopeptides Inc.,
Sanofi-Genzyme, and Takeda Oncology
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma
This email was sent by:
The International Myeloma Foundation
4400 Coldwater Canyon Ave., Suite 300
Studio City, CA 91604
Connect with the IMF InfoLine
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page